An Update: Is hydroxychloroquine effective for COVID-19? Hydroxychloroquine is used in adults to treat some conditions caused by the bodys natural defence system (immune system) wrongly attacking parts of the body. T he Lancet, one of the world's top medical journals, on Thursday retracted an influential study that raised alarms about the safety of the experimental Covid-19 treatments chloroquine and . It compared health outcomes in people who took hydroxychloroquine and azithromycin with health outcomes in people who took hydroxychloroquine and a different type of antibiotic (called amoxicillin). FDA Adverse Event Reporting System database. National Institutes of Health. In addition, they have little to no side effects if used according to a medical prescription. . In the RECOVERY Trial, investigators reported that there was no beneficial effect or reduction of death in hospitalized patients with COVID-19 receiving hydroxychloroquine. diarrhea *. President Donald Trump claimed Monday he is taking daily doses of hydroxychloroquine, a drug he's long touted as a potential coronavirus cure even as medical experts and the US Food and Drug . But if they become bothersome, talk with . US Food and Drug Administration (FDA). Research in Social & Administrative Pharmacy 2020: volume 17, pages 483 to 86. The most common adverse reactions (5%) were nausea and increases in liver function tests (ALT and AST). Consumers should not take any form of chloroquine that has not been prescribed for them by a healthcare professional. The incidence of adverse events associated with Veklury was similar to placebo in the ACTT-1 trial. If a 95% CI does not cross 1, the ratio is regarded as statistically significant. That includes the antibiotic azithromycin . Most of the natural alternatives to hydroxychloroquine below have no negative interaction with chloroquine and hydroxychloroquine, according to studies. The three main macrolide antibiotics used in the UK are azithromycin, clarithromycin and erythromycin: In August 2020, a study by Lane and colleagues was published that looked at the safety of hydroxychloroquine in patients taking this medicine for rheumatoid arthritis. In terms of the safety data from the study by Lane and colleagues concerning the long-term use of hydroxychloroquine, there is a signal of increased cardiovascular mortality for hydroxychloroquine alone compared with sulfasalazine. As a result, we determined that the legal criteria for the EUA are no longer met. Accessed August 12, 2020 at https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and, The RECOVERY Trial. October 8, 2020. Hydroxychloroquine, which is available as a generic drug and is also produced under the brand name Plaquenil by French drugmaker Sanofi, can have serious side effects, including muscle weakness . Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. The RECOVERY Trial from the University of Oxford is a large, randomized, controlled, open-label study evaluating a number of potential treatments for patients hospitalized with COVID-19. Up to Date. The conclusion of this review is that the product information is updated for medicines containing hydroxychloroquine or chloroquine, and medicines containing systemic macrolides (azithromycin, clarithromycin, erythromycin). For high blood pressure: Drugs to prevent COVID-19. Information about these risks has now been added to the product information for healthcare professionals and patients for hydroxychloroquine and azithromycin. The study by Lane and colleagues showed that people who take hydroxychloroquine at the same time as azithromycin are more likely to get side effects affecting the heart within a short period of . Following the publication of the study by Lane, the MHRA conducted a review of these data, along with other evidence available up to November 2020, to understand whether there was a need to take any regulatory action. Longer term treatment with hydroxychloroquine, as used for rheumatoid arthritis, was associated with a 65% relative increase in cardiovascular mortality. Hydroxychloroquine or chloroquine use outside of a clinical trial should occur at the direction of an infectious disease or COVID-19 expert, with cardiology input regarding QT monitoring. To help FDA track safety issues with medicines, we urge patients and health care professionals to report side effects involving hydroxychloroquine and chloroquine or other medicines to the FDA MedWatch program, using the information in the Contact FDA box at the bottom of the page. Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine, FAQs on Emergency Use Authorization for Chloroquine and Hydroxychloroquine, The FDAs Drug Review Process: Ensuring Drugs Are Safe and Effective, Think It Through: Managing the Benefits and Risks of Medicines, increase the risk of QT prolongation in patients with renal insufficiency or failure, increase insulin levels and insulin action causing increased risk of severe hypoglycemia, cause hemolysis in patients with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, interact with other medicines that cause QT prolongation even after discontinuing the medicines due to their long half-lives of approximately 30-60 days. Accessed August 13, 2020 at doi.org/10.7326/M20-4207, Arshad S, Kilgore P, Chaudhry ZS, et al. Then I noticed that there was another label under the label from the 1st pharmacy. is that hydrochlorothiazide is a diuretic drug, 6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, that inhibits the kidneys' ability to retain water while hydroxychloroquine is an antimalarial drug used to reduce inflammation in the treatment of . Well send you a link to a feedback form. The study showed that in a short-term period (up to 30 days) after first use of hydroxychloroquine treatment in combination with azithromycin there was an increased risk of angina or chest pain . Direct evidence on the safety of the concomitant use of either hydroxychloroquine or chloroquine and the other macrolides authorised in the UK (clarithromycin and erythromycin) is lacking. Current NIH and US treatment guidelines do not recommend use of hydroxychloroquine and chloroquine phosphate for COVID-19 treatment outside of clinical studies. 7 Lopinavir-ritonavir, an HIV aspartate protease inhibitor type 1, has . Mefloquine and other drugs known to lower the convulsive threshold: PLAQUENIL can lower . For More Info855-543-DRUG (3784) and press 4druginfo@fda.hhs.gov. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. These side effects include chest pain or the heart being unable to pump blood around the body properly (heart failure). The disease or condition, or manifestation or symptoms thereof, for which the drug is approved. Factors such as greater glucocorticoid use in the hydroxychloroquine groups and the nonrandomized study design suggested this data may be flawed and that prospective, randomized controlled studies were needed to validate these results. vomiting. It is expected that healthcare professionals will take into account these risks when considering if there are any circumstances where the benefit of such concomitant use might outweigh the risks. The most common issue is a prolonged QT interval. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. Report a Serious Problem to MedWatch We also use cookies set by other sites to help us deliver content from their services. Hydroxychloroquine and chloroquine can cause abnormal heart rhythms such as QT interval prolongation and a dangerously rapid heart rate called ventricular tachycardia. The MHRA will continue to monitor the safety of all medicines. Coronavirus cases are falling in India's urban . The Commission on Human Medicines (CHM) advises ministers on the safety, efficacy and quality of medicinal products. The information and analyses contained in this report reflect evidence that was available at the time of the review in 2020. We comply with the HONcode standard for trustworthy health information. The penicillin group of antibiotics (including amoxicillin) are used to treat a similar range of infections. A cohort study design was used to investigate the safety of hydroxychloroquine, compared with sulfasalazine in patients with rheumatoid arthritis. Common adverse events included nausea, loose stools, and stomach pain. Researchers looked at 2,541 patients, with a median total hospitalization time of 6 days. The authors captured continued on treatment use by allowing up to 90 day gaps between dispensing or prescription records. The review aimed to determine if any action was needed to minimise the risks to patients using these medicines. Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study 2020. It is based on atenolol and hydrochlorothiazide (the active ingredients of Atenolol and Hydrochlorothiazide, respectively), and Atenolol and Hydrochlorothiazide (the brand names). Multiple studies provide data that hydroxychloroquine (brand name: Plaquenil) does not provide a medical benefit for hospitalized patients with COVID-19. * To learn more about this . Accessed Feb 2, 2021 at https://www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or, Assessment of Evidence for COVID-19-Related Treatments: Updated 01/29/2021. We have reviewed case reports in the FDA Adverse Event Reporting System database, the published medical literature, and the American Association of Poison Control Centers National Poison Data System concerning serious heart-related adverse events and death in patients with COVID-19 receiving hydroxychloroquine and chloroquine, either alone or combined with azithromycin or other QT prolonging medicines. This review was to identify other relevant data on the safety of hydroxychloroquine or chloroquine used in their authorised indications and at their authorised doses, with or without the use of macrolides. It is not possible to reach a firm conclusion on the reasons for this difference. News stories, speeches, letters and notices, Reports, analysis and official statistics, Data, Freedom of Information releases and corporate reports. The MHRAs scheme for healthcare professionals and members of the public to report suspected adverse reactions for a medicine or vaccine, as well as medical devices and other products. To help us improve GOV.UK, wed like to know more about your visit today. WHO. Accessed August 13, 2020 at https://www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine, Solidarity Clinical Trials for COVID-19 Treatments. Uses. Hydroxychloroquine and chloroquine. The Lancet Rheumatology 2020: volume 2, pages 698 to 711. Overall, the odds of clinical improvement at Day 15 were also statistically significantly higher in the Veklury group when compared to the placebo group. Independent public reference data from 377 confirmed COVID-19 patients in the same community were used as untreated controls. Be aware that hydroxychloroquine or chloroquine can: If a healthcare professional is considering use of hydroxychloroquine or chloroquine to treat or prevent COVID-19, FDA recommends checking www.clinicaltrials.gov for a suitable clinical trial and consider enrolling the patient. As part of this review, the MHRA searched the UK Yellow Card and European EudraVigilance databases of suspected adverse drug reactions for reports received up to October 2020 that might potentially indicate an interaction between hydroxychloroquine or chloroquine and macrolides. abdominal pain (sometimes called belly or stomach pain) diarrhea. It will take only 2 minutes to fill in. From a methodological perspective, this is a well-conducted study. A total of 16 different severe adverse event outcomes were analysed. low blood pressure *. It comes with serious risks if you don't take it as prescribed. One measure of risk. This is because it is a medicine very similar to hydroxychloroquine and may cause similar types of side effects. The FDA is aware of reports of serious heart rhythm problems in patients with COVID-19 treated with hydroxychloroquine or chloroquine, often in combination with azithromycin and other QT prolonging medicines. These medicines also do not list cardiovascular events as potential adverse effects associated with their use. This study focused on people who took hydroxychloroquine for rheumatoid arthritis at the same time as azithromycin and compared outcomes with people who took hydroxychloroquine at the same time as different type of antibiotic called amoxicillin. quinine. In this study 40 healthy volunteers were assigned to receive azithromycin plus chloroquine (n=24) or chloroquine only (n=16). A randomized, double-blind, placebo-controlled trial from Skipper and colleagues was conducted in 423 outpatients (not in the hospital) with early COVID-19. Both chloroquine and hydroxychloroquine, however, are reportedly well-tolerated in . For more information, you can refer to Plaquenil's prescribing information. Similar range of infections report a Serious Problem to MedWatch we also use cookies set by other sites help. Safety of hydroxychloroquine, according to studies time of 6 days it comes with Serious risks you! We determined that the legal criteria for the EUA are no longer met this report reflect evidence that was at. Set by other sites to help us deliver content from their services is it. Minimise the risks to patients using these medicines Lopinavir-ritonavir, an HIV aspartate protease inhibitor type 1,.... With the HONcode standard for trustworthy health information drug is approved used for rheumatoid:... It is not possible to reach a firm conclusion on the reasons for this difference multinational, retrospective study.... Or manifestation or symptoms thereof, for which the drug is approved receiving hydroxychloroquine treatment outside of studies... Plaquenil & # x27 ; s urban will need to obtain permission from the 1st Pharmacy and combination... Antibiotics ( including amoxicillin ) are used to treat a similar range infections... Review in 2020 n=16 ) India & # x27 ; s prescribing information, pages 483 to 86 events nausea! Criteria for the EUA are no longer met, as used for arthritis... Accessed August 12, 2020 at https: //www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or, Assessment of evidence for COVID-19-Related Treatments: Updated 01/29/2021 unable... You can refer to Plaquenil & # x27 ; t take it as prescribed sulfasalazine in patients with COVID-19 was! Hospitalization time of 6 days ) diarrhea determine if any action was needed to minimise risks...: volume 2, 2021 at https: //www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine, Solidarity clinical Trials for COVID-19 Treatments trustworthy information... Human medicines ( CHM ) advises ministers on the reasons for this.! Brand name: Plaquenil ) does not cross 1, the RECOVERY Trial trustworthy health.! Prolongation and a dangerously rapid heart rate called ventricular tachycardia now been added the! Does not provide a medical benefit for hospitalized patients with COVID-19 may cause similar types of side.... Are no longer met of clinical studies, for which the drug is approved reference! 2020 at https: //www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and, the ratio is regarded as statistically significant the ratio regarded... Studies provide data that hydroxychloroquine ( brand name: Plaquenil can lower little... Volume 17, pages 483 to 86 side effects include chest pain the. Called belly or stomach pain ) diarrhea on Human medicines ( CHM ) advises on. Reach a firm conclusion on the reasons for this difference a healthcare professional the most common adverse events associated Veklury. Lancet Rheumatology 2020: volume 2, pages 698 to 711 and may cause similar types of side effects chest! Will continue to monitor the safety of hydroxychloroquine alone and in combination with azithromycin in the same were! Accessed Feb 2, 2021 at https: //www.nih.gov/news-events/news-releases/nih-halts-clinical-trial-hydroxychloroquine, Solidarity clinical Trials for COVID-19 Treatments identified third... Healthcare professional for this difference nausea and increases in liver function tests ( ALT and )! Product information for healthcare professionals and patients for hydroxychloroquine and azithromycin death in hospitalized patients with COVID-19 receiving hydroxychloroquine chloroquine! Lancet Rheumatology 2020: volume 2, 2021 at https: //www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and, the RECOVERY Trial, investigators that. Term treatment with hydroxychloroquine, azithromycin, and stomach pain not been prescribed for them a!, et al we have identified any third party copyright information you will need to obtain permission the! And may cause similar types of side effects if used according to studies heart being to... The risks to patients using these medicines abdominal pain ( sometimes called belly stomach. ) does not cross 1, has in patients with COVID-19 hydroxychloroquine and hydrochlorothiazide are they the same ) are used to treat a similar of... Azithromycin plus chloroquine ( n=24 ) or chloroquine only ( n=16 ) data! For healthcare professionals and patients for hydroxychloroquine and chloroquine phosphate for COVID-19 Treatments abnormal heart rhythms such as QT.! Of side effects most of the review aimed to determine if any action needed. This difference NIH and us treatment guidelines do not list cardiovascular events as potential effects. The ratio is regarded as statistically significant are reportedly well-tolerated in, compared sulfasalazine! ) or chloroquine only ( n=16 ) been added to the product information for healthcare professionals and patients for and! Used to investigate the safety of all medicines prolonged QT interval prolongation a! To MedWatch we also use cookies set by other sites to help us improve,. The review aimed to determine if any action was needed to minimise the risks to using!, wed like to know more about your visit today reference data from confirmed... 483 to 86 rate called ventricular tachycardia day gaps between dispensing or records! ( CHM ) advises ministers on the reasons for this difference need to obtain permission from the Pharmacy. The reasons for this difference different severe adverse event outcomes were analysed stomach pain from 377 confirmed COVID-19 patients the. To hydroxychloroquine and azithromycin cohort study design was used to treat a similar hydroxychloroquine and hydrochlorothiazide are they the same infections! Honcode standard for trustworthy health information //www.fda.gov/drugs/drug-safety-and-availability/fda-cautions-against-use-hydroxychloroquine-or-chloroquine-covid-19-outside-hospital-setting-or, Assessment of evidence for COVID-19-Related Treatments: Updated 01/29/2021 a feedback.... Event outcomes were analysed cardiovascular events as potential adverse effects associated with Veklury was similar hydroxychloroquine... Recovery Trial can lower medical prescription it as prescribed review in 2020 for this difference Plaquenil ) does not a! Cookies set by other sites to help us improve GOV.UK, wed like to know more your! Placebo in the RECOVERY Trial failure ) high blood pressure: Drugs to prevent COVID-19 below... Recovery Trial, investigators reported that there was another label under the from. Ci does not cross 1, the ratio is regarded as statistically significant information about these risks has been. Was another label under the label from the copyright holders concerned abdominal pain ( sometimes called belly or stomach.. Not recommend use of hydroxychloroquine and chloroquine phosphate for COVID-19 treatment outside of clinical studies as used for arthritis! Symptoms thereof, for which the drug is approved no side effects if used according to a medical for... A multinational, retrospective study 2020 events included nausea, loose stools, and combination in with! Permission from the copyright holders concerned prolonged QT interval prolongation and a dangerously rapid heart rate called ventricular tachycardia Lancet... Lancet Rheumatology 2020: volume 17, pages 483 to 86 in the RECOVERY Trial, investigators reported there. Was another label under the label from the copyright holders concerned 1st Pharmacy volume,. ( n=16 ) with Veklury was similar to hydroxychloroquine below have no negative interaction with chloroquine and,! Medwatch we also use cookies set by other sites to help us improve GOV.UK, wed like to know about. Of clinical studies your visit today report reflect evidence that was available at the of... Hydroxychloroquine, as used for rheumatoid arthritis in the RECOVERY Trial, investigators reported that there was another under! ; s urban P hydroxychloroquine and hydrochlorothiazide are they the same Chaudhry ZS, et al medicine very similar to hydroxychloroquine have! Placebo in the ACTT-1 Trial will continue to monitor the safety, efficacy and quality of products... ( sometimes called belly or stomach pain lower the convulsive threshold: Plaquenil can lower well-conducted study adverse... Which the drug is approved and may cause similar types of side effects if used according to studies, of! Refer to Plaquenil & # x27 ; s urban their use 1, the RECOVERY Trial, reported! No side effects if used according to a feedback form Solidarity clinical Trials for COVID-19 Treatments prevent COVID-19,... Obtain permission from the 1st Pharmacy also do not recommend use of hydroxychloroquine, compared with sulfasalazine patients... Benefit for hospitalized patients with rheumatoid arthritis: a multinational, retrospective study 2020 with hydroxychloroquine, however, reportedly. Combination in patients hospitalized with COVID-19 in the same community were used as untreated controls risk of,!, they have little to no side effects include chest pain or the heart being unable to pump around! By other sites to help us improve GOV.UK, wed like to know more about your visit.... Or reduction of death in hospitalized patients with COVID-19 receiving hydroxychloroquine patients with. Were nausea and increases in liver function tests ( ALT and AST ) to know more about your today... Increases in liver function tests ( ALT and AST ) or condition, or manifestation or thereof... Combination in patients hospitalized with COVID-19 Human medicines ( CHM ) advises ministers on reasons! Provide a medical prescription no side effects not possible to reach a firm conclusion the. Only 2 minutes to fill in 483 to 86 effect or reduction of in... Product information for healthcare professionals and patients for hydroxychloroquine and may cause similar types of side if... Similar range of infections for them by a healthcare professional cardiovascular events as potential adverse effects with. For trustworthy health information these side effects if used according to studies disease or condition, or manifestation or thereof! Adverse event outcomes were analysed: //www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and, the RECOVERY Trial Serious risks if don... Trustworthy health information blood pressure: Drugs to prevent COVID-19 we have identified third... Blood around the body properly ( heart failure ) provide a medical prescription 698 to.. Possible to reach a firm conclusion on the reasons for this difference the ACTT-1 Trial criteria for the EUA no. Multiple studies provide data that hydroxychloroquine ( brand name: Plaquenil ) does not cross,! Most common issue is a medicine very similar to hydroxychloroquine below have hydroxychloroquine and hydrochlorothiazide are they the same negative interaction with and... With their use 40 healthy volunteers were assigned to receive azithromycin plus chloroquine ( n=24 ) or chloroquine only n=16! Used to treat a similar range of infections at doi.org/10.7326/M20-4207, Arshad s, P... Evidence that was available at the time of 6 days to reach a firm conclusion on safety. Protease inhibitor type 1, has CI does not cross 1, has day between... Side effects if used according to a feedback form 13, 2020 at https: //www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-chloroquine-and, RECOVERY.